Please cite this paper as: Seidman et al.(2012) Quantitative review of antibody response to
inactivated seasonal influenza vaccines. Influenza and Other Respiratory Viruses 6 (1), 52 …

FLU-v, developed by PepTcell (SEEK), is a peptide vaccine aiming to provide a broadly
protective cellular immune response against influenza A and B. A randomized, double-blind …

The objective of this study is to evaluate efficacy and safety of influenza vaccine in systemic
lupus erythematosus (SLE) patients. We studied SLE patients and healthy subjects …

Background Protection against vaccine-preventable diseases is important in inflammatory
bowel disease (IBD) because of increased susceptibility and severity of infection with …

For elderly people who have low incidence of influenza, calculation of credible vaccine
effectiveness (VE) sometimes becomes difficult. Currently, VE for elderly people is …

T cells are being increasingly recognized as a significant component of influenza-specific
immune responses in humans. Although an inactivated-and a live-attenuated influenza …

Understanding whether seasonal influenza vaccines can elicit antibody and T cell
responses against the 2009 pandemic H1N1 strain is important. We compared T cell and …

Background Through test negative designs for visiting a doctor because of influenza-like
illness, many studies have found decreasing efficacy of repeated vaccination. Furthermore …

Immunogenicity of Split Inactivated Quadrivalent Influenza Vaccine in Adults with Obesity in
the 2017/2018 Season - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

The Word Health Organization estimates that due to influenza infection and virus-like
symptoms from 330 million to. 575 billion in world population, died while on the ground from …